Cliff Asness's ORGO Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 641,523 shares of Organogenesis Holdings Inc. (ORGO) worth $3.32 M, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ORGO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 986,132 shares. Largest reduction occurred in Q4 2024, reducing 1.19 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Organogenesis Holdings (ORGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organogenesis Holdings (ORGO) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -65,245 | Reduce 9.23% | 641,523 | $5.18 |
| Q3 2025 | -10,304 | Reduce 1.44% | 706,768 | $4.22 |
| Q2 2025 | -176,695 | Reduce 19.77% | 717,072 | $3.66 |
| Q1 2025 | -628,387 | Reduce 41.28% | 893,767 | $4.32 |
| Q4 2024 | -1.19 M | Reduce 43.84% | 1.52 M | $3.20 |
| Q3 2024 | +441,846 | Add 19.48% | 2.71 M | $2.86 |
| Q2 2024 | +986,132 | Add 76.88% | 2.27 M | $2.80 |
| Q1 2024 | +91,635 | Add 7.69% | 1.28 M | $2.84 |
| Q4 2023 | -351,767 | Reduce 22.80% | 1.19 M | $4.09 |
| Q3 2023 | -133,173 | Reduce 7.95% | 1.54 M | $3.18 |
| Q2 2023 | -876,280 | Reduce 34.33% | 1.68 M | $3.32 |
| Q1 2023 | +361,648 | Add 16.51% | 2.55 M | $2.13 |
| Q4 2022 | +902,291 | Add 70.04% | 2.19 M | $2.69 |
| Q3 2022 | +943,251 | Add 273.39% | 1.29 M | $3.24 |
| Q2 2022 | +188,963 | Add 121.08% | 345,023 | $4.88 |
| Q1 2022 | -39,087 | Reduce 20.03% | 156,060 | $7.62 |
| Q4 2021 | +116,971 | Add 149.63% | 195,147 | $9.24 |
| Q3 2021 | -2,422 | Reduce 3.01% | 78,176 | $14.24 |
| Q2 2021 | +64,711 | Add 407.32% | 80,598 | $16.63 |
| Q1 2021 | +15,887 | New Buy | 15,887 | $18.19 |
Cliff Asness's Organogenesis Holdings Investment FAQs
Cliff Asness first purchased Organogenesis Holdings Inc. (ORGO) in Q1 2021, acquiring 15,887 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Organogenesis Holdings Inc. (ORGO) for 20 quarters since Q1 2021.
Cliff Asness's largest addition to Organogenesis Holdings Inc. (ORGO) was in Q2 2024, adding 2,268,760 shares worth $6.35 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 641,523 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $3.32 M.
As of the Q4 2025 filing, Organogenesis Holdings Inc. (ORGO) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Organogenesis Holdings Inc. (ORGO) was 2,710,606 shares, as reported at the end of Q3 2024.